Axion Biosystems
Axion Biosystems, a leading innovator in the life sciences sector, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2008, the company has established itself as a pioneer in the development of advanced cell-based assays and electrophysiology solutions, catering to the needs of researchers in drug discovery and neuroscience. The company’s flagship products, including the Maestro platform, offer unique capabilities for real-time monitoring of cellular activity, setting Axion apart in a competitive market. With a commitment to enhancing scientific research, Axion Biosystems has achieved notable milestones, including collaborations with top-tier academic institutions and pharmaceutical companies. Their cutting-edge technology positions them as a key player in the biosystems industry, driving innovation and improving outcomes in cellular research.
DitchCarbon Score
How does Axion Biosystems's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Axion Biosystems's score of 6 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Axion Biosystems's reported carbon emissions
In 2022, Axion Biosystems reported a carbon intensity of approximately 0.308 tonnes CO2e per million euros in revenue and 3,700 kg CO2e per tonne of post-smolt production. The company has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 42% by 2030, using 2022 as the baseline year. This target has been validated by the Science Based Targets initiative (SBTi) and aligns with the necessary reductions to limit global warming to 1.5°C. Additionally, Axion Biosystems is committed to measuring and reducing its Scope 3 emissions, further enhancing its climate strategy. As a small to medium enterprise based in the United States, these initiatives reflect a proactive approach to sustainability within the technology hardware and equipment sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Axion Biosystems is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
